BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2842105)

  • 1. Effect of high salt intake on sodium, potassium-dependent adenosine triphosphatase activity in the erythrocytes of normotensive men.
    Quintanilla AP; Weffer MI; Koh H; Rahman M; Molteni A; del Greco F
    Clin Sci (Lond); 1988 Aug; 75(2):167-70. PubMed ID: 2842105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Na-K-adenosine triphosphatase and cation content in the erythrocyte in essential hypertension.
    Rahman M; Koh H; Primera MI; Del Greco F; Quintanilla AP
    J Lab Clin Med; 1986 Apr; 107(4):337-41. PubMed ID: 3007645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of treatment with hydrochlorothiazide on the red cell Na,K-adenosine triphosphatase in men with hypertension.
    Quintanilla AP; Finn M; Weffer MI; Del Greco F
    J Lab Clin Med; 1987 Nov; 110(5):583-7. PubMed ID: 2822824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of changes in dietary sodium on active electrolyte transport by erythrocytes at different stages of human pregnancy.
    Gallery ED; Rowe J; Brown MA; Ross M
    Clin Sci (Lond); 1988 Feb; 74(2):145-50. PubMed ID: 2827941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma sodium-potassium ATPase inhibition activity in low- and normal-renin hypertension.
    Keane P; Burgess E; Watanabe M; Wong T
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):9-13. PubMed ID: 1848765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dietary sodium on the Na-K ATPase inhibitor in patients with essential hypertension.
    Ashida T; Kuramochi M; Kojima S; Yoshimi H; Kawano Y; Kimura G; Abe H; Imanishi M; Yoshida K; Kawamura M
    Am J Hypertens; 1989 Jul; 2(7):560-2. PubMed ID: 2547400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the role of sodium- and potassium-activated adenosine triphosphatase inhibition in the pathogenesis of human hypertension. Changes in vascular and cardiac function following inhibition of the sodium pump in normotensive subjects and effects of calcium entry blockade.
    Kramer HJ; Glänzer K; Freitag T; Schönfeld J; Sorger M; Schlebusch H; Düsing R; Krück F
    Klin Wochenschr; 1985 Jan; 63(1):32-6. PubMed ID: 2579261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low erythrocyte Na/K-pump activity and number in northeast Thailand adults: evidence suggesting an acquired disorder.
    Tosukhowong P; Tungsanga K; Kittinantavorakoon C; Chaitachawong C; Pansin P; Sriboonlue P; Sitprija V
    Metabolism; 1996 Jul; 45(7):804-9. PubMed ID: 8692012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of erythrocyte (Na(+)-K+) ATPase activities in non-insulin-dependent diabetic patients with hyperkalemia.
    Mimura M; Makino H; Kanatsuka A; Yoshida S
    Metabolism; 1992 Apr; 41(4):426-30. PubMed ID: 1313528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of renal sodium-potassium-adenosine triphosphatase by aldosterone. Effect of high physiologic levels on enzyme activity in isolated rat and rabbit tubules.
    Mujais SK; Chekal MA; Jones WJ; Hayslett JP; Katz AI
    J Clin Invest; 1985 Jul; 76(1):170-6. PubMed ID: 2991336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte ghost Na+,K+-ATPase and blood pressure.
    Rygielski D; Reddi A; Kuriyama S; Lasker N; Aviv A
    Hypertension; 1987 Sep; 10(3):259-66. PubMed ID: 3040586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium space and intravascular volume: dietary sodium effects in cystic fibrosis and healthy adolescent subjects.
    Legris GJ; Dearborn D; Stern RC; Geiss CL; Hopfer U; Douglas JG; Doershuk CF
    Pediatrics; 1998 Jan; 101(1 Pt 1):48-56. PubMed ID: 9417150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-erythrocyte sodium and (Na+,K+-activated)-ATPase concentration and urinary aldosterone excretion in spontaneously hypertensive rats.
    Berglund G; Sigström L; Lundin S; Karlberg BE; Herlitz H
    Clin Sci (Lond); 1981 Feb; 60(2):229-32. PubMed ID: 6263538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte cation metabolism in salt-sensitive hypertensive blacks as affected by dietary sodium and calcium.
    Zemel MB; Kraniak J; Standley PR; Sowers JR
    Am J Hypertens; 1988 Oct; 1(4 Pt 1):386-92. PubMed ID: 2850820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of effect of aldosterone on sodium efflux catalyzed by the human erythrocyte Na+, K+-ATPase in vitro.
    Díez J
    J Steroid Biochem; 1987; 27(4-6):963-6. PubMed ID: 2826914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell Na+,K+-ATPase in men with newly diagnosed or previously treated essential hypertension.
    Ringel RE; Hamlyn JM; Hamilton BP; Pinkas GA; Chalew SA; Berman MA
    Hypertension; 1987 May; 9(5):437-43. PubMed ID: 3032788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of alteration of sodium potassium pump of erythrocytes from patients with chronic renal failure.
    Cheng JT; Kahn T; Kaji DM
    J Clin Invest; 1984 Nov; 74(5):1811-20. PubMed ID: 6094614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race and sex differences in erythrocyte Na+, K+, and Na+-K+-adenosine triphosphatase.
    Lasker N; Hopp L; Grossman S; Bamforth R; Aviv A
    J Clin Invest; 1985 Jun; 75(6):1813-20. PubMed ID: 2989333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced Na+, K(+)-ATPase activity in patients with pseudohypoaldosteronism.
    Bistritzer T; Evans S; Cotariu D; Goldberg M; Aladjem M
    Pediatr Res; 1994 Mar; 35(3):372-5. PubMed ID: 8190530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.